Effect of catechins and high-temperature-processed green tea extract on scavenging reactive oxygen species and preventing Aβ_1–42 fibrils’ formation in brain microvascular endothelium

Abstract

The present study investigated the effect of high-temperature-processed green tea extract (HTP_GTE) and its bioactive components on the reduction of reactive oxygen species (ROS) and amyloid-beta (Aβ) protein in human microvascular endothelial cells. Compared to Aβ_1–42-only treatment, pretreatment of HTP_GTE was revealed to effectively inhibit ROS generation (P<0.05). HTP_GTE and catechins not only inhibit Aβ_1–42 fibril formation but also destabilize preformed Aβ_1–42 fibrils. The presence of HTP_GTE, Aβ_1–42 fibril formation was significantly inhibited in a dose-dependent manner at 12.5–100 μg/ml of HTP_GTE, showing 86–56%, respectively. Treatment of various concentrations of HTP_GTE and catechins steadily destabilized the preformed Aβ_1–42 fibrils for 24 h in a dose-dependent manner. It was observed that the gallated groups such as epigallocatechin gallate, epicatechin gallate, gallocatechin gallate, and catechin gallate more effectively disturbed Aβ_1–42 fibril formation and destabilized the preformed Aβ_1–42 fibrils than the non-gallated group. Taken together, these findings supported that sterilized green tea could be promising natural anti-amyloidogenic agents associated with therapeutic approaches in Alzheimer’s disease by scavenging ROS generation and Aβ fibril in the brain tissue.

Keywords:

• High-temperature-processed green tea extract
• Catechins
• Reactive oxygen species
• Aβ_1–42 fibrils
• Blood-brain barrier

Acknowledgment

This research was part of a projected titled “Development of Global Senior-friendly Health Functional Food Materials from Marin Resources” funded by the Ministry of Oceans and Fisheries, Korea. Also, this work was supported in part by the US National Institutes of Health (NIH) grant, NS091102 to KSK.

Disclaimer statement

Contributor None.

Conflicts of interest The authors have declared no conflict of interest.

Ethics approval None.

ORCID

Eun-Hye Choi http://orcid.org/0000-0002-6849-3222